Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional − prospective study to inform referral for germline testing

In this prospective observational study, a standardized and weighted assessment of family history identified a clinically meaningful subset of patients with NSCLC enriched for familial cancer patterns. This framework provides a pragmatic approach to optimize referral to genetic counseling and supports targeted germline screening strategies beyond traditional smoking-based risk models. Prospective validation in the planned translational phase will clarify the clinical utility of this approach.

Authors

Institutions

Publication Details

Journal
Lung Cancer
Published
2026-02-26
DOI
https://doi.org/10.1016/j.lungcan.2026.109346
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional − prospective study to inform referral for germline testing

M. Russano, F.M. Venanzi, Francesco Pantano, Fiorella Gurrieri et al.
Lung Cancer
Lung Cancer Treatments and Mutations
article

Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional − prospective study to inform referral for germline testing

M. Russano, F.M. Venanzi, Francesco Pantano, Fiorella Gurrieri, Priscilla Cascetta, Fabrizio Citarella, A. Cortellini, Giulia La Cava, E. Milanesi, B. Vincenzi, Sara Oresti, A Delmonte, Emanuele Claudio Mingo, Massimo Di Maio, Tiziana Vavalà, Roberto Ferrara, Pierfilippo Crucitti, Giuseppe Tonini, Kazuki Takada, Carla Lintas, Giulia Di Giovanni, Mattero Fiorenti, Lucio Crinò
article en

Abstract

In this prospective observational study, a standardized and weighted assessment of family history identified a clinically meaningful subset of patients with NSCLC enriched for familial cancer patterns. This framework provides a pragmatic approach to optimize referral to genetic counseling and supports targeted germline screening strategies beyond traditional smoking-based risk models. Prospective validation in the planned translational phase will clarify the clinical utility of this approach.

Lung CancerVol. 214
Vita-Salute San Raffaele University (IT), Università Campus Bio-Medico (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Humanitas Gavazzeni (IT), IRCCS Ospedale San Raffaele (IT), Campus Bio Medico University Hospital (IT), Saiseikai Fukuoka General Hospital (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Openalex Percentile: Top 43%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.